Cormedix (STU:19KA) Accumulated Depreciation : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cormedix Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cormedix's quarterly accumulated depreciation increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-0.48 Mil) but then stayed the same from Dec. 2023 (€-0.48 Mil) to Mar. 2024 (€0.00 Mil).

Cormedix's annual accumulated depreciation increased from Dec. 2021 (€-0.32 Mil) to Dec. 2022 (€-0.43 Mil) and increased from Dec. 2022 (€-0.43 Mil) to Dec. 2023 (€-0.48 Mil).

Cormedix Accumulated Depreciation Historical Data

The historical data trend for Cormedix's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix Accumulated Depreciation Chart

Cormedix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.22

-0.25

-0.32

-0.43

-0.48

Cormedix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-0.48	-

Cormedix Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cormedix Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cormedix's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cormedix (STU:19KA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

CRMD:USA 19KA:Germany

Address

300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922

Website

https://www.cormedix.com

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is to develop its lead product candidate, DefenCath, for potential commercialization in the United States (U.S.) and other key markets.

Cormedix (STU:19KA) Headlines

No Headlines